Headquarters
2200 MARKET ST, STE 604, GALVESTON, TX 77550-1532, US
GALVESTON, TX, US
CHRYSALIS BIOTHERAPEUTICS INC
From the company
Chrysalis BioTherapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of treatments for serious respiratory disorders and acute radiation exposure. It develops regenerative peptide drugs, led by TP508 (Rusalatide acetate, Chrysalin), to restore vascular function and activate stem cells. Incorporated in Delaware in 2012, it is based in Galveston, Texas.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.